论文部分内容阅读
<正> Purpose: To evaluate the additional intraocular pressure lowering efficacy and safety of travoprost 0.004% compared with la-tanoprost 0.005%, in patients with open-angle glaucoma or ocular hypertension, whose intraocular pressure was not adequat